Artiva Biotherapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 17.7% | 17.7% | -27.3% |
| FY2024 | -35.0% | -35.0% | -31.2% |
| FY2025 | -76.3% | -76.3% | -64.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 17.7% | 17.7% | -27.3% |
| FY2024 | -35.0% | -35.0% | -31.2% |
| FY2025 | -76.3% | -76.3% | -64.0% |